Fundraising FoxFulcrum Global Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
A bio-pharmaceutical and real estate holding company that conducts cannabis genomic research through its subsidiaries to develop improved cannabis and hemp strains for medical and industrial applications, while maintaining agricultural licenses and significant real estate holdings.
Tucson, US
Glenn E Martin(Director and Chief Executive Officer)Nicole M Breen(Director, Secretary and Treasurer)inPatrick E Williams(Director)
Co-investorsClay Capital
WeedOUT develops a biological herbicide using proprietary sterile weed pollen to control resistant weeds in agriculture.
AgTechBiotech
Efrat Lidor Nili(Founder)in
PartnerKevin Lockett· solo GP
Co-investorsRadicle GrowthZORAClay Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.